Text size
Home / News & Events/ 2023 Scientific Meeting


Our FIRST in-person meeting was held September 12th & 13th at the Sheraton Hamilton. 

Stay tuned for a recap of the event coming soon!

The 2023 Sepsis Canada Scientific Meeting endeavors to promote patient partner engagement, enhance understanding of sepsis prognosis, facilitate accurate diagnosis, and explore innovative treatment approaches. This event aims to increase awareness about sepsis and its profound impact on individuals, while offering educational opportunities to healthcare professionals on the latest research findings and evidence-based practices for effective sepsis management. Additionally, the conference seeks to foster discussions among experts and stakeholders to develop a comprehensive national strategy for the formulation of sepsis policies and protocols in Canada.

Who Should Attend

  • Healthcare Professionals: Physicians, nurses, researchers, and allied health professionals involved in sepsis care and research.
  • Patient Partners: Individuals who have personally experienced sepsis or family members and advocates representing those affected by sepsis.
  • Policy Makers: Government officials, policymakers, and stakeholders invested in shaping sepsis policies for Canada.
  • Industry Representatives: Companies and organizations with a focus on sepsis-related products, services, and research.
  • Trainees

Event Highlights

  • Keynote Presentations & Panel Discussions: Renowned speakers will share their expertise and insights on sepsis-related topics.
  • Poster Sessions: Trainees will showcase their latest research through poster presentations, encouraging networking and knowledge exchange.
  • Networking Opportunities: Networking breaks will facilitate meaningful connections among attendees from diverse backgrounds and specialties.

Event Sponsor

We are proud to announce that the 2023 Sepsis Canada Scientific Meeting is sponsored by bioMérieux. Their generous support contributes to the success of this event in advancing sepsis research and patient care.



As the continuing COVID-19 pandemic is changing the landscape of health research and care, the importance of knowledge dissemination to improve the health literacy of ALL Canadians and empower them to take charge of their own health can’t be understated

“Transforming the Trajectory of Sepsis Research: A Multidisciplinary Forum that Redefines the Who, What, Why, and How”, will take place at the Art Gallery of Hamilton on World Sepsis Day, September 13th. As infrastructure in Hamilton, and across Canada, from coast to coast, light up pink for World Sepsis Day, this event will kick off important conversations on sepsis research and care. 

Learn more about our Cafe Scientifique event (free) HERE.



Aminmohamed Manji

Age-dependent pulmonary microvascular endothelial cell barrier dysfunction under basal and septic conditions

Western University

Fatima Sheikh

Social Determinants of Sepsis: A Prospective, Pilot Observational Cohort Study

McMaster University

Fatima Sheikh

Analysis of the Factors that Contributed to the Passage of Rory's Regulations Using the 3I+E Framework: Implications for Future Sepsis Policy

McMaster University

Forough Jahandideh

Biological sex differences in response to antibiotic treatment in a murine model of fecal-induced peritonitis: a pilot study

Ottawa University

Gemma Barber

Characterization of immune cell specificity after ex vivo antigen stimulation during critical illness

Schulich School of Medicine and Dentistry (Western University), Robarts Research Institute, Department of Microbiology and Immunology

Keshikaa Suthaaharan

Investigation into Sepsis-Associated Alterations of the Arterial Endothelium as a Priming Event for Atherogenesis: Protocol for Preclinical Studies

McMaster University

Muhadisa Ali

Sepsis in Canada: An Environmental Scan of Research Activity

McMaster University

Rasa Eskandari

Continuous monitoring of microcirculatory deterioration in septic rats with non-invasive optical spectroscopy

Western University

Victoria Chechulina

High-Cost Users and Healthcare Resource Utilization After Sepsis: A Systematic Review Protocol

Western University

Victoria Labuda

Optimizing ex vivo stimulation for characterization of immune responses in critical illness

University of Western Ontario, Department of Medicine in the division of Critical Care Medicine

About our Speakers

Waleed + Al-Hazzani Dr. Waleed Al-Hazzani Sepsis Care & Discharge from ICU: Lessons Post-COVID-19
Kathleen  + Andreas Kathleen Andreas Recognition & Management of Sepsis in Paediatrics
Kali + Barrett Dr. Kali Barrett The Economic Burden of Sepsis | Rory's Regulations: Lessons for Canada
Christine + Caron Christine Caron Patient Partner Engagement across the Continuum of Research
Alison  + Fox-Robichaud Dr. Alison Fox-Robichaud Opening & Closing Remarks
Allan  + Garland Dr. Allan Garland Sepsis Epidemiology: Incidence / Prevalence

Professor Nick Daneman is a Clinician Scientist in the Division of Infectious Diseases, in the Department of Medicine, at Sunnybrook Health Sciences Centre, at the University of Toronto, and senior scientist at ICES and infection prevention physician at Public Health Ontario. His research program is focused on optimizing the prevention and treatment of health care associated infection, with particular interest in Clostridium difficile infections, infections of critical care, surgical site infections, and antibiotic stewardship. 

Evan is the Chief Scientific Officer of Asep Medical Inc., a company dedicated to addressing antibiotic failure through the development of novel therapeutics and medical diagnostics. In addition, he is a Research Associate working with Bob Hancock at the University of British Columbia developing synthetic peptides for pharmaceutical applications as well as novel diagnostics for sepsis. He is currently working on advancing the company’s proprietary synthetic antibiofilm peptide technology towards clinical applications to address hard-to-treat biofilm-associated infection. In addition, he is part of the team developing a novel sepsis diagnostic assay capable of aiding in the risk assessment of patients for progression to severe sepsis as the enter the emergency department or intensive care unit of a hospital. Evan holds a PhD in Biochemistry from the University of Calgary and has authored or contributed to 52 peer-reviewed publications, four book chapters and is a co-inventor on two patent families. 

Michelle + Kho Dr. Michelle Kho Improving Access to Sepsis Clinical Trials
Niranjan 'Tex'  + Kissoon Dr. Niranjan 'Tex' Kissoon The Global Perspective
Na + Li Dr. Na Li Strategies to Recognize Sepsis using Electronic Medical Records

Charu Kaushic, PhD, FCAHS, is the Scientific Director of the Canadian Institutes of Health Research (CIHR)-Institute of Infection and Immunity. She is a tenured Full Professor in the Department of Medicine at McMaster University, Hamilton, Canada. In her role at CIHR-III she is responsible for making decisions nationally and internationally for CIHR’s strategic investments. She is currently Chair of GloPID-R, a global consortium of funders in pandemic preparedness and emergency response research. During the COVID-19 pandemic, she has been involved in shaping CIHR’s research response to the pandemic and served on Canada’s COVID-19 National Immunity Task Force and Health Canada’s Variants of Concern Leadership Group. Dr. Kaushic manages a large interdisciplinary research program in women’s reproductive health, specifically basic, clinical and translational research examining susceptibility and immune responses to sexually transmitted viruses, HIV-1 and HSV-2. She has received numerous national and international awards for her research and leadership. Recently she was inducted into the Government of Canada’s Women of Impact Online Gallery and the Canadian Academy of Health Sciences. 

Patricia  + Liaw Dr. Patricia Liaw Advancing Sepsis Prognosis and Treatment Through Pre-Clinical Research
Osama + Loubani Dr. Osama Loubani Opening & Closing Remarks
Wynona + Marleau Wynona Marleau Patient Partner Engagement across the Continuum of Research
Marie-Hélène + Masse Marie-Hélène Masse Clinical Trials: A Research Coordinators Perspective on Sepsis Trials
Melissa  + Parker Dr. Melissa Parker Lessons from a Pediatric Clinical Trial: Where to next?
Kristine  + Russell Kristine Russell Impacts of Engaging with Patient Advisory Councils on Long-Term Recovery for Sepsis Survivors and Their Families: A Case Study Approach
Deborah + Schonfeld Dr. Deborah Schonfeld Recognition & Management of Sepsis in Paediatrics
Fatima + Sheikh Fatima Sheikh Rory's Regulations: Lessons for Canada

Dr. Wojcik is academically trained as a scientist, with a PhD in Microbiology from the University of Calgary and a BSc in Cellular, Molecular and Microbial Biology. Her PhD focused on elucidating antimicrobial resistance mechanisms of a Cystic Fibrosis opportunistic pathogen. Following her PhD, for 6 years, Kasia worked as an educator and Intravital Microscopy Specialist supporting the research of investigators in the Live Cell Imaging Facility, at the Snyder Institute for Chronic Diseases, University of Calgary. She specialized in fluorescence microscopy for imaging of inflammatory and chronic disease models. She consulted on study design, developed methods and taught surgical approaches, sample preparation, and microscopy. During this time, she also achieved her Project Management Professional (PMP) designation, with the Project Management Institute. This allowed her, to make a transition to industry, where for over 5 years she served as a Medical Scientific Liaison in the Respiratory then Cardiology Franchises at Novartis Pharmaceuticals Canada. In 2022, Dr. Wojcik joined bioMerieux Canada and works as an infectious diseases Medical Science Liaison.